Epitopes for Thyroid-Stimulating Antibodies in Graves' Sera: A Possible Link of Heterogeneity to Differences in Response to Antithyroid Drug Treatment *

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1758-1767

  Kim, Won Bae ^a   Cho, Bo Youn ^a,d   Park, Hye Young ^a   Lee, Hong Kyu ^a   Kohn, Leonard D ^b   Tahara, Kazuo ^c   Koh, Chang Soon ^a  

^a Seoul National University   (South Korea)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CHIBA UNIVERSITY   (Japan)

^d Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CRICETINAE; CRICETULUS GRISEUS;

ANTITHYROID AGENT; CHORIONIC GONADOTROPIN RECEPTOR; EPITOPE; IMMUNOGLOBULIN G; LIOTHYRONINE; LUTEINIZING HORMONE RECEPTOR; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ANIMAL CELL; ARTICLE; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; DRUG EFFICACY; GENETIC HETEROGENEITY; GENETIC TRANSFECTION; GOITER; GRAVES DISEASE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAT; THYROID CELL;

ANIMALS; ANTITHYROID AGENTS; CELL LINE; CHO CELLS; CRICETINAE; EPITOPES; GOITER; GRAVES DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, THYROID-STIMULATING; RATS; RECEPTORS, THYROTROPIN; THYROXINE; TRANSFECTION; TRIIODOTHYRONINE;

EID: 0029937902     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.5.8626830     Document Type: Article

References (37)

1. Kohn LD, Kosugi S, Ban T, et al. 1992 Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. Int Rev Immunol. 9:135-165.
2. Kohn LD, Shimura H, Shimura Y, et al. 1995 The thyrotropin receptor. Vitam Horm 50:287-384.
3. Kohn LD, Giuliani C, Montani V, et al. 1995 Antireceptor immunity. In: Rayner D, Cooke A, Champion B, eds. Thyroid immunity. Austin/Georgetown: Landes Biomedical; 115-170.
4. Kosugi S, Ban T, Akamizu T, Kohn LD. 1992 Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid stimulating antibodies and with thyroid stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol. 6:168-180.
5. Kosugi S, Ban T, Kohn LD. 1993 Identification of thyroid stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. Mol Endocrinol. 7:114-130.
6. Tahara K, Ban T, Minegishi T, Kohn LD. 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or Immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun. 179:70-77.
7. Tahara K, Yamamoto K, Yoshida S. 1992 Demonstration of two types of thyroid stimulating antibodies with different epitopes on the human thyrotropin receptor [Abstract]. Thyroid. 2(Suppl):113.
8. Tahara K, Yamamoto K, Kohn LD, et al. 1993 Three types of thyroid stimulating antibodies recognize different epitopes on the human thyrotropin receptor. In: Nagataki S, Mori T, Torizuka K, eds. 80 years of Hashimoto's disease. Amsterdam: Elsevier; 675-677.
9. Hidaka A, Ban T, Panesar NS, Minegishi T, Kohn LD, Tahara K. 1994 The extracellular domain of the lutropin/choriogonadotropin receptor has distinct sites important for agonist activity and high affinity binding: the agonist site is fully responsive to thyrotropin. Thyroid. 4:447-457.
10. Kohn LD, Valente WA, Grollman EF, Aloj SM, Vitti P. 1986 Clinical determination and/or quantification of thyrotropin and a variety of thyroid stimulatory or inhibitory factors performed in vitro with an improved thyroid cell line FRTL-5. US Patent 4:609,622.
11. Freshney RI. Measurement of viability and cytotoxicity. In: Culture of animal cells: a manual of basic technique. New York: Wiley-Liss; 288.
12. Southgate K, Creagh F, Teece M, Kingwood C, Smith BR. 1984 A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol (Oxf). 20:539-548.
13. Kasagi K, Konishi J, Iida Y, et al. 1987 A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. Acta Endocrinol (Copenh). 115:30-36.
14. Shong YK, Cho BY, Lee HK, Koh C-S, Min HK, Lee M. 1989 Measurements of thyroid growth immunoglobulins in Graves' disease and their relationship with thyroid stimulating antibody and thyrotropin binding inhibitor immunoglobulins. In: Lee M, Koh C-S, Eastman CJ, Nagataki S, eds. Progress in thyroidology 1989. Seoul: Korea Publishing; 25-28.
15. Cho BY, Shong YK, Lee HK, Koh C-S, Min HK, Lee M. 1988 Assay of thyroid stimulating antibodies using cultured rat thyroid cells (FRTL-5) in Graves' disease: fundamental assessments and clinical significance. Korean J Intern Med. 34:183-195.
16. Fenzie GF, Vitti P, Marcocci C, Chiovato L, Macchia E. 1986 TSH receptor autoantibodies affecting thyroid cell function. In: Pinchera A, Ingbar SH, McKenzie JM, Fenzie GF, eds. Thyroid autoimmunity. New York/London: Plenum Press; 83-90.
17. Mitani Y, Shigemasa C, Taniguchi S, et al. 1989 Studies on antiTSH receptor antibodies in autoimmune thyroid disease. In: Lee M, Koh C-S, Eastman CJ, Nagataki S, eds. Progress in thyroidology 1989. Seoul: Korea Publishing; 143-146.
18. Vitti P, Rotella CM, Valente WA, et al. 1983 Characterization of the optimal stimulatory effects of Graves' monoclonal and serum immunoglobulin G on adenosine 3′,5′-monophosphate production in FRTL-5 thyroid cells: a potential clinical assay. J Clin Endocrinol Metab. 57:782-791.
19. Vitti P, Elisei R, Tonacchera M, et al. 1993 Detection of thyroid stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J Clin Endocrinol Metab. 76:499-503.
20. Kohn LD, Valente WA, Alvarez FV, et al. 1985 New procedures for detecting Graves' immunoglobulins. In: Walfish P, Wall R, Volpe R, eds. Autoimmunity and the thyroid. New York: Academic Press; 217-247.
21. Valente WA, Vitti P, Yavin Z, et al. 1982 Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease. Proc Natl Acad Sci USA. 79:6680-6684.
22. Kohn LD, Alvarez F, Marcocci C, et al. 1986 Monoclonal antibody studies defining the organ and properties of autoantibodies in Graves' disease. Ann NY Acad Sci. 475:157-173.
23. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD. 1992 Mutation of alanine 623 in the 3rd cytoplasmic loop of the rat TSH receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J Biol Chem. 267:24153-24156.
24. Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD. 1993 Substitutions of different regions of the 3rd cytoplasmic loop of the TSH receptor have selective effects on constitutive, TSH- and TSH receptor autoantibody-stimulated phosphoinositide and cAMP signal generation. Mol Endocrinol. 7:1009-1020.
25. Kosugi S, Kohn LD, Akamizu T, Mori T. 1994 The middle portion of the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation. Mol Endocrinol. 8:498-509.
26. Kosugi S, Mori T, Imura H. 1989 Mechanisms by which low salt condition increases sensitivity of thyroid stimulating antibody assay. Endocrinology. 125:410-417.
27. Ueda Y, Sugawa H, Akamizu T, et al. 1993 Immunoglobulin G that interferes with thyroid stimulating antibody measurements can be eliminated specifically by incubation with synthetic peptides corresponding to partial sequences of the human thyrotropin receptor. Thyroid. 3:111-117.
28. Ueda Y, Sugawa H, Akamizu T, et al. 1995 Presence of heterogeneous thyroid stimulating antibodies in sera from individual Graves' patients as shown by synthesized TSH-R peptide application. Eur J Endocrinol. 132:62-68.
29. Kosugi S, Akamizu T, Takai S, Prabhakar B, Kohn LD. 1991 The extra cellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' sera but unrelated to receptor function as well as epitopes having different roles for high affinity TSH binding and the activity of thyroid stimulating antibodies. Thyroid. 1:321-330.
30. Kosugi S, Ban T, Akamizu T, Kohn LD. 1991 Site directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors: relationship of functional and immunogenic domains. J Biol Chem. 266:19413-19418.
31. Kosugi S, Ban T, Akamizu T, Kohn LD. 1991 Further characterization of a high-affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients. Biochem Biophys Res Commun. 180:1118-1124.
32. Takai O, Desai RK, Seetharamaiah GS, et al. 1991 Prokaryotic expression of the thyrotropin receptor and identification of the immunogenic region of the protein using synthetic peptides. Biochem Biophys Res Commun. 179:319-326.
33. Desai RK, Dallas JS, Gupta MK, et al. 1993 Dual mechanism of perturbation of thyrotropin mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR derived peptides. J Clin Endocrinol Metab. 77:658-663.
34. 2 isomerase-like activities together with altered basal and thyrotropin-responsive thymidine incorporation into DNA. Endocrinology. 127:1526-1540.
35. Valente WA, Vitti P, Rotella CM, et al. 1983 Antibodies that promote thyroid growth: a distinct population of thyroid-stimulating autoantibodies. N Engl J Med. 309:1028-1034.
36. Di Cerbo A, Di Girolamo M, Guardabasso V, et al. 1992 Immunoglobulins from Graves' patients stimulate phospholipase-A2 in FRTL5 thyroid cells. J Clin Endocrinol Metab. 74:585-592.
37. Di Cerbo A, Di Paola R, Bonati M, et al. 1995 Subgroups of Graves' patients identified on the basis of the biochemical activities of their immunoglobulins. J Clin Endocrinol Metab. 80:2785-2790.